ghk-cu recommended daily dosage and Protocol: A Medical Provider's Guide to the 30-Day Cycle GHK-Cu Dosage: Clinical Guidance for

Begin conservatively and adjust only under appropriate guidance

Neurological Relevance Preclinical evidence suggests broader neuroprotective potential: In traumatic brain injury models, SS-31 reduced mitochondrial swelling, neuronal loss, and neuroinflammation Aged mice treated with SS-31 showed significantly improved exercise tolerance, muscle strength, and mitochondrial efficiency Studies demonstrate protection against ischemic injury and enhanced cardiac output Phase 3 trials are ongoing for dry age-related macular degeneration and primary mitochondrial myopathy (Stealth BioTherapeutics pipeline) Implications for Brain Aging Mitochondrial dysfunction is a hallmark of brain aging and neurodegeneration

This can be limiting in terms of the overall level of recovery

It depends on the cause and how much the nerve was compressed